Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Marie, Osdoit"'
Autor:
Julie Labrosse, Marie Osdoit, Anne-Sophie Hamy, Florence Coussy, Jean-Yves Pierga, Fabien Reyal, Enora Laas
Publikováno v:
PLoS ONE, Vol 15, Iss 6, p e0234173 (2020)
Although identified to be at a higher risk of relapse, no consensus exists on the treatment of breast cancer (BC) patients with no pathological complete response after neoadjuvant chemotherapy (NAC). The benefit of adjuvant chemotherapy (ADJ) in this
Externí odkaz:
https://doaj.org/article/0135f188cba24fc580dd0add747412de
Autor:
Anne-Sophie Hamy, Lauren Darrigues, Enora Laas, Diane De Croze, Lucian Topciu, Giang-Thanh Lam, Clemence Evrevin, Sonia Rozette, Lucie Laot, Florence Lerebours, Jean-Yves Pierga, Marie Osdoit, Matthieu Faron, Jean-Guillaume Feron, Marick Laé, Fabien Reyal
Publikováno v:
PLoS ONE, Vol 15, Iss 6, p e0234191 (2020)
IntroductionThe Residual Cancer Burden (RCB) quantifies residual disease after neoadjuvant chemotherapy (NAC). Its predictive value has not been validated on large cohorts with long-term follow up. The objective of this work is to independently evalu
Externí odkaz:
https://doaj.org/article/00a331b30e81432888d7d03ba4451387
Autor:
Enora Laas, Jean Guillaume Feron, Fatima Laki, Virginie Fourchotte, Marie Osdoit, Bernard Asselain, Fabien Reyal, Fabrice Lecuru
Publikováno v:
Bulletin du Cancer. 109:1059-1065
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76b2fabff9f8ae2f6719e8bb30f7be21
https://doi.org/10.1016/j.bulcan.2022.04.013
https://doi.org/10.1016/j.bulcan.2022.04.013
Autor:
Enora, Laas, Jean Guillaume, Feron, Fatima, Laki, Virginie, Fourchotte, Marie, Osdoit, Bernard, Asselain, Fabien, Reyal, Fabrice, Lecuru
Publikováno v:
Bulletin du cancer. 109(10)
Surgical studies have specific issues, such as quality assurance on procedures, standardization of techniques, surgeon effect, timing of randomization, blinding respect or choice of the reference arm. All these difficulties conducted to criticism man
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6994145993d2ac17026870eecd6ae8eb
https://pubmed.ncbi.nlm.nih.gov/35995611
https://pubmed.ncbi.nlm.nih.gov/35995611
Autor:
Cheryl Ewing, Gretchen M. Ahrendt, Anne M. Wallace, Gregor Krings, Helen Krontiras, Christina Yau, Kimberly Cole, Sunati Sahoo, Julie E. Lang, Dina Kokh, Brigid K. Killelea, Akiko Chiba, Tod Tuttle, W. Fraser Symmans, Molly Klein, Arpana Naik, Yunn-Yi Chen, Marie Osdoit, Constantine Godellas, Roshni Rao, Nora Jaskowiak, Laura J. Esserman, Bev Parker, Julia Tchou, Rita A. Mukhtar, Ronald Balassanian, Smita Asare, Jodi M. Carter, M. Catherine Lee, Eleni A. Tousimis, Laila Khazai, Shannon Tierney, Judy C. Boughey, Rachael Lancaster
Publikováno v:
Cancer Research. 80:P3-08
Background: Patients who achieve a pathological complete response (pCR- defined as no invasive cancer) after neoadjuvant chemotherapy (NAC) for breast cancer (BC) have improved outcomes, but there is still controversy about the significance of residu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66b516c77eeb79849992c7472cd2bfb6
https://doi.org/10.1158/1538-7445.sabcs19-p3-08-16
https://doi.org/10.1158/1538-7445.sabcs19-p3-08-16
Publikováno v:
The Lancet. Oncology. 23(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddddbea2d2396857c39b38fb7c41ab12
https://pubmed.ncbi.nlm.nih.gov/35240096
https://pubmed.ncbi.nlm.nih.gov/35240096
Autor:
Christina Yau, Marie Osdoit, Marieke van der Noordaa, Sonal Shad, Jane Wei, Diane de Croze, Anne-Sophie Hamy, Marick Laé, Fabien Reyal, Gabe S Sonke, Tessa G Steenbruggen, Maartje van Seijen, Jelle Wesseling, Miguel Martín, Maria del Monte-Millán, Sara López-Tarruella, Judy C Boughey, Matthew P Goetz, Tanya Hoskin, Rebekah Gould, Vicente Valero, Stephen B Edge, Jean E Abraham, John M S Bartlett, Carlos Caldas, Janet Dunn, Helena Earl, Larry Hayward, Louise Hiller, Elena Provenzano, Stephen-John Sammut, Jeremy S Thomas, David Cameron, Ashley Graham, Peter Hall, Lorna Mackintosh, Fang Fan, Andrew K Godwin, Kelsey Schwensen, Priyanka Sharma, Angela M DeMichele, Kimberly Cole, Lajos Pusztai, Mi-Ok Kim, Laura J van 't Veer, Laura J Esserman, W Fraser Symmans, Kathi Adamson, Kathy S. Albain, Adam L. Asare, Smita M. Asare, Ron Balassanian, Heather Beckwith, Scott M. Berry, Donald A. Berry, Judy C. Boughey, Meredith B. Buxton, Yunn-Yi Chen, Beiyun Chen, A. Jo Chien, Stephen Y. Chui, Amy S. Clark, Julia L. Clennell, Brian Datnow, Angela M. DeMichele, Xiuzhen Duan, Kirsten K. Edmiston, Anthony D. Elias, Erin D. Ellis, Laura L. Esserman, David M. Euhus, Oluwole Fadare, Michael D Feldman, Andres Forero-Torres, Barbara B. Haley, Hyo S. Han, Shuko Harada, Patricia Haugen, Teresa Helsten, Gillian L. Hirst, Nola M. Hylton, Claudine Isaacs, Kathleen Kemmer, Qamar J. Khan, Laila Khazai, Molly E. Klein, Gregor Krings, Julie E. Lang, Lauren G. LeBeau, Brian Leyland-Jones, Minetta C. Liu, Shelly Lo, Janice Lu, Anthony Magliocco, Jeffrey B. Matthews, Michelle E. Melisko, Paulette Mhawech-Fauceglia, Stacy L. Moulder, Rashmi K. Murthy, Rita Nanda, Donald W. Northfelt, Idris T. Ocal, Olufunmilayo Olopade, Stefan Pambuccian, Melissa Paoloni, John W. Park, Barbara A. Parker, Jane Perlmutter, Garry Peterson, Mara Rendi, Hope S. Rugo, Sunati Sahoo, Sharon Sams, Ashish Sanil, Husain Sattar, Richard B. Schwab, Ruby Singhrao, Katherine Steeg, Erica Stringer-Reasor, W. Fraser Symmans, Ossama Tawfik, Debasish Tripathy, Megan L. Troxell, Laura J. van't Veer, Sara J. Venters, Tuyethoa Vinh, Rebecca K. Viscusi, Anne M. Wallace, Shi Wei, Amy Wilson, Douglas Yee, Jay C. Zeck
Publikováno v:
I-SPY 2 Trial Consortium 2022, ' Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer : a multicentre pooled analysis of 5161 patients ', The Lancet Oncology, vol. 23, no. 1, pp. 149-160 . https://doi.org/10.1016/S1470-2045(21)00589-1
The Lancet. Oncology, vol 23, iss 1
The Lancet Oncology, 23(1), 149-160. Lancet Publishing Group
The Lancet. Oncology, vol 23, iss 1
The Lancet Oncology, 23(1), 149-160. Lancet Publishing Group
Background: Previous studies have independently validated the prognostic relevance of residual cancer burden (RCB) after neoadjuvant chemotherapy. We used results from several independent cohorts in a pooled patient-level analysis to evaluate the rel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9b5a03d8d05046179f5dcc364471bd0
https://research.vumc.nl/en/publications/4b35d135-33e6-4bf5-982e-dab0f5ddbfd8
https://research.vumc.nl/en/publications/4b35d135-33e6-4bf5-982e-dab0f5ddbfd8
Autor:
Julie Labrosse, Milena Benque, Angélique Bobrie, Thanh Lam, Hilde Merckelbagh, Thomas Balezeau, Beatriz Grandal, Marie Osdoit, Anne-Sophie Hamy, Fabien Reyal, Florence Coussy, Loic Ferrer, Jean-Guillaume Feron, Julien Guerin, Clara Sebbag, Enora Laas, Maël Priour, Ines Abdennebi
Publikováno v:
JCO Clinical Cancer Informatics. :1-12
PURPOSE To apply text mining (TM) technology on electronic medical records (EMRs) of patients with breast cancer (BC) to retrieve the occurrence of a pregnancy after BC diagnosis and compare its performance to manual curation. MATERIALS AND METHODS T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c812637888ed799ea9a690cd72efb25c
https://doi.org/10.1200/cci.19.00031
https://doi.org/10.1200/cci.19.00031
Autor:
Floriane Jochum, Anne-Sophie Hamy, Thomas Gaillard, Lise Lecointre, Paul Gougis, Élise Dumas, Beatriz Grandal, Jean-Guillaume Feron, Enora Laas, Virginie Fourchotte, Noemie Girard, Lea Pauly, Marie Osdoit, Elodie Gauroy, Lauren Darrigues, Fabien Reyal, Cherif Akladios, Fabrice Lecuru
Publikováno v:
Cancers; Volume 14; Issue 23; Pages: 5987
Survival disparities persist in ovarian cancer and may be linked to the environments in which patients live. The main objective of this study was to analyze the global impact of the area of residence of ovarian cancer patients on overall survival. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f2c79dbcdf094bacc7e3095170a8c4d
https://doi.org/10.3390/cancers14235987
https://doi.org/10.3390/cancers14235987
Autor:
Marie Osdoit, Christina Yau, W. Fraser Symmans, Judy C. Boughey, Cheryl A. Ewing, Ron Balassanian, Yunn-Yi Chen, Gregor Krings, Anne M Wallace, Somaye Zare, Oluwole Fadare, Rachael Lancaster, Shi Wei, Constantine V. Godellas, Ping Tang, Todd M Tuttle, Molly Klein, Sunati Sahoo, Tina J. Hieken, Jodi M. Carter, Beiyun Chen, Gretchen Ahrendt, Julia Tchou, Michael Feldman, Eleni Tousimis, Jay Zeck, Nora Jaskowiak, Husain Sattar, Arpana M. Naik, Marie Catherine Lee, Marilin Rosa, Laila Khazai, Mara H. Rendi, Julie E. Lang, Janice Lu, Ossama Tawfik, Smita M. Asare, Laura J. Esserman, Rita A. Mukhtar
Publikováno v:
JAMA Surgery. 157:1034
ImportancePathologic complete response (pCR) after neoadjuvant chemotherapy (NAC) in breast cancer strongly correlates with overall survival and has become the standard end point in neoadjuvant trials. However, there is controversy regarding whether
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fe544f8ebfc338c6f75ee08341aa566
https://doi.org/10.1001/jamasurg.2022.4118
https://doi.org/10.1001/jamasurg.2022.4118